Heracleum persicum Essential Oil Nanoemulsion: A Nanocarrier System for the Delivery of Promising Anticancer and Antioxidant Bioactive Agents

Essential oils are important compounds for the prevention and/or treatment of various diseases in which solubility and bio-accessibility can be improved by nanoemulsion systems. Heracleum persicum oil nanoemulsion (HAE-NE) was prepared and biological properties were investigated against human breast cancer cells and normal human fibroblasts foreskin. Particle size, zeta potential and poly dispersity index were 153 nm, −47.9 mV and 0.35, respectively. (E)anethole (57.9%), terpinolene (13.8%), G-terpinene (8.1%), myrcene (6.8%), hexyl butyrate (5.2%), octyl bu-tanoate (4.5%) and octyl acetate (3.7%) was detected in nanoemulsion. Proliferation of cancer cells at IC50 = 2.32 \ub5g/mL was significantly (p < 0.05) inhibited, and cell migration occurred at 1.5 \ub5L/mL. The HAE-NE at 1.5, 2.5 and 3.5 \ub5g/concentration up-regulated caspase 3 and enhanced sub-G1 peak of cell cycle with nil cytotoxic effects in the liver, kidney and jejunum of mice. Villus height, villus width, crypt depth and goblet cells in mice group fed with 10 and 20 mg/kg body weight of HAE-NE improved. Cellular redox state in the liver indicated 10 and 20 mg/kg body weight of nanoemulsion significantly up-regulated the expression of SOD, CAT and GPx genes. Heracleum persicum oil na-noemulsion could be an eco-friendly nanotherapeutic option for pharmaceutical, cosmetological and food applications

Response to dietary supplementation of glutamine in broiler chickens subjected to transportation stress

The main purpose of this study was to determine effects of glutamine supplementation on performance and blood parameters including Hsp70 and acute phase protein when chicken were subjected to transportation stress. A total of four hundred day-old-male cobb-500 chicks were obtained directly from a local hatchery. The chicks were allotted to two groups as: immediate placement (1 hour after hatching) with access to feed and water and placement after 24h transportation without access to feed and water. The experiment consisted of a factorial arrangement of 2 different diets and 2 different time of placement. Chicks from each placement group were fed either basal diet or basal diet + 1% glutamine from 1 to 21 days of age. The results indicated that dietary glutamine improved the body weight gain and feed conversion ratio significantly when chicks were subjected to delayed or immediate placement. In conclusion, supplementing chicken with glutamine in diet can reduce negative effects of delayed access to feed and water during transportation. Moreover, APP concentration and HSP70 level were positively affected when chicks supplemented with glutamine in the diet

Causes of abortion in Iranian sheep flocks and associated risk factors

Abortion is a major issue in sheep husbandry. It can result in significant economic losses and a severe public health risk. This survey assessed the infectious and non-infectious causes of abortion in Iranian sheep flocks and determined the main risk factors. In this cross-sectional survey, causes of abortion were evaluated in 757 sheep flocks, and risk factors were analysed. A checklist containing general animal information for each abortion outbreak evaluated was filled in. Data were analysed using univariate tests and multivariable binary logistic regression analysis. In this sense, parity, gestational age of the aborted fetus, vaccination protocol, mineral supplementation and history of stillbirth showed significant associations with abortion. Infectious agents such as Coxiella burnetti (22.7%), Chlamydia abortus (12.3%) and Brucella melitensis (10.4%) were the most frequently isolated in the investigated flocks, with more than 2% of abortion rates. On the other hand, non-infectious agents such as trauma, pregnancy toxaemia and vitamin E/Se deficiency were involved in those flocks with low abortion rates (less than 10%). Results revealed multiple causes of abortion outbreaks among Iranian sheep flocks, which need careful investigation to identify possible aetiology and risk factors. Further studies are necessary to evaluate if these factors are similar to other countries in the same region

Mode of action of Jatropha curcas phorbol esters in bovine kidney cells

Jatropha meal is a potential biofeed for animal production however, the presence of phorbol esters (PEs) in the meal limits its utilization. The PEs caused severe toxic manifestations in animals. The information on the mechanisms of toxicity at the cellular level is rather limited. Therefore, this research was conducted to investigate the mode of action of PEs by evaluating the biochemical, biological and molecular responses of cells exposed to PEs. Phorbol esters from Jatropha meal were isolated and identified as Jatropha factor (JF) JFC1, JFC2, JFC3 and a mixture of JFs (C4, C5 and C6). These PEs exhibited cytotoxic activity towards bovine kidney cells and induced significant morphological changes. The PEs severely altered the redox status of the cells which resulted in the occurrence of oxidative stress. Moreover, the PEs up-regulated the expressions of PKC-βII, proto-oncogenes, pro-inflammatory cytokines and elevated the caspase-3 activity in the cells. All PEs were toxic, but JFC1 and JFC2 appeared to be more toxic to the bovine kidney cells as compared to the JFC3 and the mixture of JFs. The results indicated that the cytotoxic activity of Jatropha meal PEs was elicited through induction of oxidative stress and inflammation of the cells

No Evidence of Hepatitis C Virus Infection in Individuals with Cardiovascular Disease in Mashhad

Background and Aim: Hepatitis C virus (HCV) infection is one of the leading causes of morbidity and mortality worldwide. It has been hypothesized that a number of bacteria and viruses might be involved in the pathogenesis of cardiovascular disease. The aim of this study was to define the prevalence of HCV in patients with cardiovascular disease in comparison with a control group. Methods: In this study, 281 individuals including 143 cardiovascular patients and 138 healthy controls were assessed for identification of HCV antibodies. The data collection was done between April 2016 and February 2017. The prevalence of HCV antibodies was determined by the enzyme-linked immunosorbent assay (ELISA) method. Results: There was no HCV infection in both patients with or without cardiovascular disease. There was a significant direct correlation between cardiovascular diseases and mean level of FPG (Fasting plasma glucose) (p<0.001). Also the Systolic and Diastolic blood pressures were significantly higher in the patients with cardiovascular disease (p<0.001 and p=0.005, respectively). Conclusion: The results of this study show that no evidence of HCV infection is found among a group of cardiovascular patients in the city of Mashhad. *Corresponding Author: Zahra Meshkat; Email: [email protected] Please cite this article as: Shakeri Hoseinabad M, Aryan E, Ghayour Mobarhan M, Moohebati M, Abolbashari S, Gholoobi A, Houshyar Chechaklou A, Yaghoubi A, Meshkat M, Meshkat Z. No Evidence of Hepatitis C Virus Infection in Individuals with Cardiovascular Disease in Mashhad. Arch Med Lab Sci. 2021;7:1-5 (e13). https://doi.org/10.22037/amls.v7.3344

Yield and yield components of common bean as influenced by wheat residue and nitrogen rates under water deficit conditions

Incorporation of crop residues into agricultural system has become a worldwide efficient practice for enhancing crop production. The main objectives of this experiment was to investigate the major role of incorporating wheat (Triticum aestivum L.) residues and nitrogen (N) fertilizers rates under different water requirements (WR) on growth, seed yield and yield components of common bean (Phaseolus vulgaris L.). The results showed that seed yield under 80% WR in retained crop residue plots was & SIM;11% higher than WR treatment with no residue incorporation. Seed yield was not significantly different between residue retention and removal treatments in 2016, whereas it was higher (12% and 17%) under residue retained plots compared to removed ones in subsequent years. Seed yields responded to N up to 170 and 225 kg ha(-1) in removed and retained residue treatments, respectively in 2017 and 2018. Annual increment of seed yield in residue retained plots (36%) was 2.11 times higher than the residue removed ones (17%). There was higher soil N content in 50% residue retention with 225 kg N ha(-1) under both water deficit treatments in all years. The highest soil organic carbon (SOC) was achieved with normal irrigation in retained residue plots with 225 kg N ha(-1) in all years. Overall, wheat residue incorporation into the soil and N-supply substantially contributed to counteracting yield declines of common bean under water deficit conditions.& nbsp;(c) 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Peer reviewe

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation